Dysphotopsia

2

Review clinical trials related to Dysphotopsia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Impact of Iridotomy/Iridectomy Size on Postoperative Pupillary Block and Dysphotopsia Following DMEK

Descemet membrane endothelial keratoplasty (DMEK) is the standard surgical treatment for corneal endothelial disorders. A postoperative pupillary block may occur despite routine preoperative laser iridotomy or intraoperative surgical iridectomy. Insufficient size or incomplete patency of the iridotomy/iridectomy (IT) may contribute to this complication, while excessively large openings may be associated with postoperative dysphotopsia. This prospective observational study investigates the association between IT size measured by anterior segment optical coherence tomography (AS-OCT) and the occurrence of postoperative pupillary block and dysphotopsia after DMEK.

Participants needed: 100
Trial details
Biological sex: AllType: ObservationalSponsor: University of LeipzigUpdated: Jul 2, 2026
Eligibility criteria

Adults aged ≥ 18 years [+4]

Inability to provide informed consent or refusal to participate [+3]

Status: Recruiting

Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

The goal of this clinical investigation is to evaluate visual acuity and contrast sensitivity in low lighting conditions using several different testing devices, and measure nighttime side effects of intraocular lens (IOL) implants after cataract surgery. Researchers will compare the results for three different types of IOLs to see how each lens contributes to overall visual function, patient experience and satisfaction. Participants will: * Complete two different questionnaires about their current vision * Undergo visual testing using several different devices

Participants needed: 120
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Dr. Daniel H. Chang, MDUpdated: Apr 6, 2026Locations: 1Duration: 1 Day
Eligibility criteria

Minimum 22 years of age [+4]

Any clinically significant pupil abnormalities (non-reactive, fixed pupils, or a... [+5]